Drug Type Gene therapy |
Synonyms LVP-K PTEN |
Target |
Action inhibitors |
Mechanism PTEN inhibitors(Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glioblastoma | Preclinical | South Korea | 01 Jun 2025 | |
| Pancreatic Cancer | Discovery | South Korea | 01 Jun 2025 |





